The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
Fitgurú on MSN
Is this blood pressure pill the secret to living longer? New study finds anti-aging potential
Scientists have discovered that the hypertension drug rilmenidine mimics the life-extending benefits of calorie restriction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback